Insulin Resistance Unraveled: Hormonal Correlations in Gestational Diabetes

Hormones, Insulin Resistance, and Lipids in Gestational Diabetes

  • Siyu Chen
  • Xuru Bai
  • Xuerui Yin
  • Lan Bai Department of Clinical Laboratory, The First People’s Hospital of Chengdu Shuangliu District /Sichuan University West China Airport Hospital
Keywords: gestational diabetes mellitus, sex hormone-binding globulin, cortisol, insulin-like growth factor 1, insulin resistance, glucose and lipid metabolism

Abstract


Background: To investigate the correlation between the variations of cortisol and insulin-like growth factor 1 (IGF-1) and sex hormone binding globulin (SHBG) levels with insulin resistance and glucolipid metabolism in gestational glucose diabetics.

Methods: The study included 110 pregnant women diagnosed with gestational diabetes mellitus in the GDM group,and 130 healthy pregnant women in the control group. Data collection,examination of relevant indexes,and comparison of differences in indexes between groups were conducted. Pearson correlation analysis was utilized to identify risk variables associated with GDM development,while binary logistic regression was employed to determine risk factors for GDM development.

Results: The GDM group showed significantly greater levels of FPG,HbA1c,FINS,TG,FFA,Lp-PLA2,HOMA-IR,Cortisol,and IGF-1 compared to the control group (P<0.05),but considerably lower levels of SHBG,and HOMA-β. HOMA-IR was found to be positively correlated with FPG,HbA1c,FINS,TG,FFA,Lp-PLA2,Cortisol and IGF-1,whereas,negatively correlated with SHBG. FINS and SHBG were found to be independent protective factors for GDM (OR=0.463,0.801,P<0.05),whereas,HbA1c,TG,FFA,and gestational BMI were found to be independent risk factors for GDM (OR=1.992,4.234,1.990,1.629,P<0.05).

Conclusion: SHBG,IGF-1,and Cortisol are all linked to glucose-lipid metabolism indices,and aberrant serum hormone expression is a major contributor to insulin resistance.

References

1. Ye W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. Bmj-Brit Med J 2022; 377: e067946.
2. Haider N, Lebastchi J, Jayavelu AK, Batista TM, Pan H, Dreyfuss JM, et al. Signaling defects associated with insulin resistance in nondiabetic and diabetic individuals and modification by sex. J Clin Invest 2021; 131(21): e151818.
3. Kushi R, Hirota Y, Ogawa W. Insulin resistance and exaggerated insulin sensitivity triggered by single-gene mutations in the insulin signaling pathway. Diabetol Int 2021; 12(1): 62-7.
4. Watamoto Y, Futawaka K, Hayashi M, Matsushita M, Mitsutani M, Song Z, et al. IGF-1 regulate the expression of uncoupling protein 2 via FOXO1. Growth Factors 2019; 37(5-6): 247-56.
5. Stern C, Schwarz S, Moser G, Cvitic S, Jantscher-Krenn E, Gauster M, et al. Placental Endocrine Activity: Adaptation and Disruption of Maternal Glucose Metabolism in Pregnancy and the Influence of Fetal Sex. Int J Mol Sci 2021; 22(23): 12722.
6. Akalestou E, Genser L, Rutter GA. Glucocorticoid Metabolism in Obesity and Following Weight Loss. Front Endocrinol 2020; 11: 59.
7. Martin-Estal I, Castorena-Torres F. Gestational Diabetes Mellitus and Energy-Dense Diet: What Is the Role of the Insulin/IGF Axis? Front Endocrinol 2022; 13: 916042.
8. McIntyre HD, Catalano P, Zhang C, et al. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019. 5(1): 47 .
9. Szmuilowicz ED, Josefson JL, Metzger BE. Gestational Diabetes Mellitus. Endocrin Metab Clin 2019; 48(3): 479-93.
10. Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci 2018; 19(11): 3342.
11. Ademoglu EN, Gorar S, Keskin M, Carlioglu A, Ucler R, Erdamar H, et al. Serum nesfatin-1 levels are decreased in pregnant women newly diagnosed with gestational diabetes. Arch Endocrin Metab 2017; 61(5): 455-9.
12. James DE, Stockli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Bio 2021; 22(11): 751-71.
13. Mustaniemi S, Morin-Papunen L, Keikkala E, Ohman H, Surcel HM, Kaaja R, et al. Associations of low sex hormone-binding globulin and androgen excess in early pregnancy with fasting and post-prandial hyperglycaemia, gestational diabetes, and its severity. Diabetes-Metab Res 2023; 39(2): e3599.
14. Yin B, Ding L, Chen Z, Chen Y, Zhu B, Zhu Y. Combining HbA1c and insulin resistance to assess the risk of gestational diabetes mellitus: A prospective cohort study. Diabetes Res Clin Pr 2023; 199: 110673.
15. Tawfeek MA, Alfadhli EM, Alayoubi AM, El-Beshbishy HA, Habib FA. Sex hormone binding globulin as a valuable biochemical marker in predicting gestational diabetes mellitus. Bmc Womens Health 2017; 17(1): 18.
16. Quan L, Wang L, Wang J, Yuwen B, Zhu J. Association between sex hormone binding globulin gene polymorphism and type 2 diabetes mellitus. Int J Clin Exp Patho 2019; 12(9): 3514-20.
17. Hill M, Parizek A, Simjak P, Koucky M, Anderlova K, Krejci H, et al. Steroids, steroid associated substances and gestational diabetes mellitus. Physiol Res 2021; 70(Suppl4): S617-34.
18. Liu X, Wang N, Gao Z. β-Carotene regulates glucose transport and insulin resistance in gestational diabetes mellitus by increasing the expression of SHBG. Clin Exp Pharmacol P 2022; 49(12): 1307-18.
19. Mather KJ, Kim C, Christophi CA, Aroda VR, Knowler WC, Edelstein SE, et al. Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program. J Clin Endocr Metab 2015; 100(10): 3778-86.
20. Martinez-Varea A, Martinez-Saez C, Domenech J, Desco-Blay J, Monfort-Pitarch S, Hueso M, et al. sFlt-1/PlGF Ratio at 24 Weeks Gestation in Twin Pregnancies as a Predictor of Preeclampsia or Fetal Growth Restriction. Fetal Diagn Ther 2022; 49(4): 206-14.
21. Yamamoto N, Oshima T, Yoshihara K, Aoyama T, Hayashi T, Yamada T, et al. Clinicopathological significance and impact on outcomes of the gene expression levels of IGF-1, IGF-2 and IGF-1R, IGFBP-3 in patients with colorectal cancer: Overexpression of the IGFBP-3 gene is an effective predictor of outcomes in patients with colorectal cancer. Oncol Lett 2017; 13(5): 3958-66.
22. Balachandiran M, Bobby Z, Dorairajan G, Gladwin V, Vinayagam V, Packirisamy RM. Decreased maternal serum adiponectin and increased insulin-like growth factor-1 levels along with increased placental glucose transporter-1 expression in gestational diabetes mellitus: Possible role in fetal overgrowth. Placenta 2021; 104: 71-80.
23. Pecks U, Wolter M, Borchers C, Smith D, Maass N, Glocker M, et al. PP032. Apolipoprotein profiling in umbilical cord blood of intrauterine growth restricted (IUGR) neonates. Pregnancy Hypertens 2013; 3(2): 78.
24. Bal M, Sahin EG, Demirtas O, Kurt S, Tasyurt A. Vitamin D deficiency in pregnancy is not associated with diabetes mellitus development in pregnant women at low risk for gestational diabetes. Turk J Obstet Gyneco 2016; 13(1): 23-6.
25. Tien NS, Bui MT, Trung DH, Dinh LT, Phi TNN, Tran T, et al. Relationship Between Maternal Serum Cortisol and Maternal Insulin Resistance and Fetal Ultrasound Characteristics in Gestational Diabetes Mellitus. Diabet Metab Synd Ob 2023; 16: 365-72.
26. Morais J, Severo JS, Beserra JB, de Oiveira A, Cruz K, de Sousa MS, et al. Association Between Cortisol, Insulin Resistance and Zinc in Obesity: a Mini-Review. Biol Trace Elem Res 2019; 191(2): 323-30.
Published
2024/06/28
Section
Original paper